Japanese drug giant Eisai has entered into a business acquisition agreement with Alfresa Holdings Corporation concerning the splitting off of Eisai’s consolidated pharmaceutical manufacturing and marketing subsidiary Sannova. The effective date of the split is scheduled to be March 31, 2016. Sannova produces a variety of formulations such as granules, powders, tablets, liquids, ointments, creams and lotions of prescription pharmaceuticals, generics, over the counter pharmaceuticals and ...